Use of Botulinum Toxin (Botox®) in Cases of Refractory Pelvic Floor Muscle Dysfunction

2014, 177 2013 Pacik, 2014, Understanding and treating vaginismus: A multimodal approach, Int Urogynecol J, 25, 1613, 10.1007/s00192-014-2421-y Abdo, 2004, Prevalence of sexual dysfunctions and correlated conditions in a sample of Brazilian women–Results of the Brazilian study on sexual behavior (BSSB), Int J Impot Res, 16, 160, 10.1038/sj.ijir.3901198 Lewis, 2004, Epidemiology/risk factors of sexual dysfunction, J Sex Med, 1, 35, 10.1111/j.1743-6109.2004.10106.x Spector, 1990, Incidence and prevalence of the sexual dysfunctions: A critical review of the empirical literature, Arch Sex Behav, 19, 389, 10.1007/BF01541933 Rahman, 2018, Female sexual dysfunction among muslim women: increasing awareness to improve overall evaluation and treatment, Sex Med Rev, 6, 535, 10.1016/j.sxmr.2018.02.006 Lamont, 1978, Vaginismus, Am J Obstet Gynecol, 131, 633, 10.1016/0002-9378(78)90822-0 Pacik, 2011, Vaginismus: Review of current concepts and treatment using botox injections, bupivacaine injections, and progressive dilation with the patient under anesthesia, Aesthetic Plast Surg, 35, 1160, 10.1007/s00266-011-9737-5 Engman, 2010, Long-term coital behaviour in women treated with cognitive behaviour therapy for superficial coital pain and vaginismus, Cogn Behav Ther, 39, 193, 10.1080/16506070903571014 Rosenbaum, 2009, [The role of physical therapy in the treatment of female sexual dysfunction], Harefuah, 148, 606 Sims, 1861, On vaginismus, Trans Obstet Soc London, 3, 356 Dick, 2021, Application of botulinum neurotoxin in female sexual and genitourinary dysfunction: A review of current practices, Sex Med Rev, 9, 57, 10.1016/j.sxmr.2020.01.003 Butrick, 2009, Pelvic floor hypertonic disorders: Identification and management, Obstet Gynecol Clin North Am, 36, 707, 10.1016/j.ogc.2009.08.011 Karp, 2019, Methodological approaches to botulinum toxin for the treatment of chronic pelvic pain, vaginismus, and vulvar pain disorders, Int Urogynecol J, 30, 1071, 10.1007/s00192-018-3831-z Ferreira, 2012, Botulinum toxin for vaginismus treatment, Pharmacology, 89, 256, 10.1159/000337383 Brin, 1997, Treatment of vaginismus with botulinum toxin injections, Lancet, 349, 252, 10.1016/S0140-6736(05)64862-3 Park, 2009, Successful use of botulinum toxin type a in the treatment of refractory postoperative dyspareunia, Obstet Gynecol, 114, 484, 10.1097/AOG.0b013e3181998ce1 Bertolasi, 2009, Botulinum neurotoxin type A injections for vaginismus secondary to vulvar vestibulitis syndrome, Obstet Gynecol, 114, 1008, 10.1097/AOG.0b013e3181bb0dbb Ghazizadeh, 2004, Botulinum toxin in the treatment of refractory vaginismus, Obstet Gynecol, 104, 922, 10.1097/01.AOG.0000141441.41178.6b Pacik, 2017, Vaginismus treatment: Clinical trials follow up 241 patients, Sex Med, 5, e114, 10.1016/j.esxm.2017.02.002 Shafik, 2000, Vaginismus: Results of treatment with botulin toxin, J Obstet Gynaecol, 20, 300, 10.1080/01443610050009674 Fageeh, 2011, Different treatment modalities for refractory vaginismus in western Saudi Arabia, J Sex Med, 8, 1735, 10.1111/j.1743-6109.2011.02247.x Brown, 2006, Subjective and objective outcomes of botulinum toxin type A treatment in vestibulodynia: Pilot data, J Reprod Med, 51, 635 Romito, 2004, Botulinum toxin for the treatment of genital pain syndromes, Gynecol Obstet Invest, 58, 164, 10.1159/000079620 Tandon, 2019, Botulinum toxin for chronic pelvic pain in women with endometriosis: A cohort study of a pain-focused treatment, Reg Anesth Pain Med, 10.1136/rapm-2019-100529 Brueseke, 2012, Ischiorectal fossa abscess after pelvic floor injection of botulinum toxin, Am J Obstet Gynecol, 206, e7, 10.1016/j.ajog.2011.12.023 Morrissey, 2015, Botulinum toxin A injections into pelvic floor muscles under electromyographic guidance for women with refractory high-tone pelvic floor dysfunction: a 6-month prospective pilot study, Female Pelvic Med Reconstr Surg, 21, 277, 10.1097/SPV.0000000000000177 Yaraghi, 2019, Int Urogynecol J, 30, 1821, 10.1007/s00192-018-3836-7 Autonomic, 1999 Eccleston, 2008, Botulinum toxin for urogenital conditions, Int J STD AIDS, 19, 797, 10.1258/ijsa.2008.008255